Retirement Planning Company of New England’s GSK GSK Stock Holding History

Retirement Planning Company of New England’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,123	Closed	-$610K	–	217
2023 Q2	$610K	Sell	17,123 -222	-1%	-$7.96K	0.35%	91
2023 Q1	$617K	Sell	17,345 -126	-0.7%	-$4.41K	0.37%	92
2022 Q4	$614K	Buy	17,471 +1,501	+9%	+$50K	0.4%	84
2022 Q3	$469K	Buy	+15,970	New	+$605K	0.34%	99
2022 Q2	–	Sell	-15,951	Closed	-$868K	–	221
2022 Q1	$868K	Buy	15,951 +394	+3%	+$21.4K	0.49%	62
2021 Q4	$857K	Buy	+15,557	New	+$809K	0.42%	62

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Retirement Planning Company of New England's GSK Position: Q3 2023 in Review

Retirement Planning Company of New England sold out of GSK (GSK) in Q3 2023, closing a stake of 17,123 shares — an estimated $610K sold.

Retirement Planning Company of New England first reported a position in GSK in Q4 2021 and held it in 6 quarters. The position peaked at $868K in Q1 2022. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Retirement Planning Company of New England reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
Retirement Planning Company of New England sold 17,123 GSK shares in Q3 2023, an estimated $610K.
Retirement Planning Company of New England first reported a position in GSK in Q4 2021 and held it in 6 quarters.
Retirement Planning Company of New England's GSK position peaked at $868K in Q1 2022.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Retirement Planning Company of New England's 13F filing for Q3 2023, filed 13 Nov 2023.